Cargando…

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia

Detalles Bibliográficos
Autores principales:	Chao, Hong-Ying, Sheng, Guang-Ying, Zhang, Xiu-Wen, Zhou, Min, Shen, Hong-Jie, Chen, Su-Ning, Cen, Jian-Nong, Sun, Yi-Wu, Chen, Tao, Lu, Xu-Zhang, Zhang, Ri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956779/ https://www.ncbi.nlm.nih.gov/pubmed/29722345 http://dx.doi.org/10.4103/0366-6999.231521

Ejemplares similares

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
por: Tsai, Cheng-Hong, et al.
Publicado: (2017)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Integrative molecular subtypes of acute myeloid leukemia
por: Mo, Qianxing, et al.
Publicado: (2023)

Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia
por: Maung, Kyaw Ze Ya, et al.
Publicado: (2018)

Identification of a novel NPM1 mutation in acute myeloid leukemia
por: Yao, Yiyi, et al.
Publicado: (2023)

Molecular predictors of post-transplant survival in acute myeloid leukemia
por: Qin, Tong, et al.
Publicado: (2017)

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia
por: Wang, Huafeng, et al.
Publicado: (2022)

Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia
por: Zhang, Keyuan, et al.
Publicado: (2023)

Acute Myeloid Leukemia Masquerading as Acute Appendicitis
por: Shen, Kai, et al.
Publicado: (2017)

Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse‐risk acute myeloid leukaemia: A single‐centre retrospective analysis
por: Song, Bao‐Quan, et al.
Publicado: (2023)

Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene
por: Zhang, Xuehong, et al.
Publicado: (2023)

The clinical impact of IKZF1 mutation in acute myeloid leukemia
por: Zhang, Xiang, et al.
Publicado: (2023)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Plasmacytoid Dendritic Cells Proliferation Coexisted with Acute Myeloid Leukemia
por: Wang, Min, et al.
Publicado: (2018)

Genomic landscape of hyperleukocytic acute myeloid leukemia
por: Largeaud, Laetitia, et al.
Publicado: (2022)

Heterogeneous prognosis among KIT mutation types in adult acute myeloid leukemia patients with t(8;21)
por: Qin, Ya-Zhen, et al.
Publicado: (2018)

Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
por: Mo, Jianshan, et al.
Publicado: (2023)

A case of de novo dynamin 2 (DNM2)-related centronuclear myopathy with electrical but not clinical myotonia
por: Huang, Xiao, et al.
Publicado: (2020)

Characteristic immunophenotype and gene co-mutational status orchestrate to optimize the prognosis of CEBPA mutant acute myeloid leukemia
por: Chen, Xinjie, et al.
Publicado: (2023)

Impact of blood count recovery on outcomes of acute myeloid leukemia patients achieving morphologic leukemia-free state
por: Cheng, Wen-Yan, et al.
Publicado: (2018)

Impact of Covid-19 on the treatment of acute myeloid leukemia
por: Ferrara, Felicetto, et al.
Publicado: (2020)

Orthodontic treatment for a patient with acute myeloid leukemia
por: Hsin-Chung Cheng, Johnson, et al.
Publicado: (2022)

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
por: Eisfeld, A-K, et al.
Publicado: (2017)

Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype
por: Ibáñez, Mariam, et al.
Publicado: (2020)

Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant
por: Pabon, Cindy M., et al.
Publicado: (2021)

AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears
por: Yu, Zebin, et al.
Publicado: (2023)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

The immunometabolic landscape of the bone marrow microenvironment in acute myeloid leukemia
por: Xu, Binyan, et al.
Publicado: (2022)

t(4;11) translocation in hyperdiploid de novo adult acute myeloid leukemia: A case report
por: Zhang, Min-Yu, et al.
Publicado: (2022)

Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia
por: Sun, Jie, et al.
Publicado: (2016)

First-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia
por: Jin, Xin, et al.
Publicado: (2022)

B Cell Deficiency in Patients with Relapsed and Refractory Acute Myeloid Leukemia
por: Goswami, Meghali, et al.
Publicado: (2020)

Asciminib in chronic myeloid leukemia: many questions still remain to be answered
por: Eşkazan, Ahmet Emre
Publicado: (2021)

Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting
por: DiNardo, Katherine W., et al.
Publicado: (2023)

The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia
por: Qin, Ya-Zhen, et al.
Publicado: (2021)

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
por: Wang, Miao, et al.
Publicado: (2023)

Pattern and prognostic value of FLT3‐ITD mutations in Chinese de novo adult acute myeloid leukemia
por: Liu, Song‐Bai, et al.
Publicado: (2018)

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants
por: Cicconi, Laura, et al.
Publicado: (2021)

ANP32A dysregulation contributes to abnormal megakaryopoiesis in acute megakaryoblastic leukemia
por: Sun, Xueqin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pnjm1p7b9l2of5lvaaok1vfme1